Evaluation of acute toxicity of Rasaparpati - An Ayurvedic mercurial compound in Albino rats
Keywords:Rasaparpati, HgS, Acute toxicity, O.E.C.D, Safety
This study aimed to investigate the preparation process of Rasaparpati, an Ayurvedic medicine containing Mercury that is commonly used to treat various ailments. The dangers of using Mercury as a therapeutic agent are acknowledged, and Ayurveda emphasizes purifying heavy metals before human use. The present study assessed the acute toxicity of Rasaparpati in albino rats to ensure its safe consumption.Methodology
Following ethical guidelines and O.E.C.D. (423) protocol, Rasaparpati was prepared traditionally, and an acute toxicity study was conducted. Two groups of female Wistar rats were administered 300mg/kg and 2000mg/kg of Rasaparpati, and their behavioral changes, signs of toxicity, and mortality were closely monitored. Hematological, biochemical, and histopathological parameters were also examined for any changes. The data obtained were analyzed and evaluated using an unpaired t-test, with p < 0.05 considered significant.Results
No deaths were observed following the administration of Rasaparpati in an acute toxicity study. There were no hematological or biochemical toxicity indications, even at ten time the therapeutic dose. However, the histopathological analysis revealed mild changes likely to heal and repair. These non-specific and reversible changes in rat cells suggest similar outcomes in human cells.Conclusions
The acute toxicity study of Rasaparpati suggests its safety for animal use, indicating potential safety for human consumption. No adverse effects or mortality were observed, even at a dosage ten times higher than the therapeutic dose. However, more extensive research with larger sample sizes and control groups is recommended.
How to Cite
Copyright (c) 2023 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.